StandardAero, Inc. (SARO)

Achilles Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	70.73	10.97	-35.06	-21	-30.71
Depreciation & Amortization	188.38	187.08	197.1	195.22	196.36
Other Amortization	10.09	11.92	15.31	16.24	15.15
Loss (Gain) From Sale of Assets	0.68	0.48	-0.01	-0.2	1.86
Asset Writedown & Restructuring Costs	-	-	-	5.83	-
Stock-Based Compensation	19.42	17.38	-	-	-
Other Operating Activities	-12.11	-7.45	-10.14	-24.87	-55.98
Change in Accounts Receivable	-329.24	-150.64	-111.39	-181.69	-108.86
Change in Inventory	-108.86	-138.01	-91.25	-53.05	-113.56
Change in Accounts Payable	170.56	104.38	-25.74	95.06	97.63
Change in Unearned Revenue	155.07	43.17	137.35	4.44	82.55
Change in Income Taxes	-22.24	-9.67	-34.27	18.11	17.24
Change in Other Net Operating Assets	-6.57	6.71	25.99	-26.83	29.08
Operating Cash Flow	135.9	76.33	67.89	27.26	130.75
Operating Cash Flow Growth	61.75%	12.43%	149.05%	-79.15%	-
Capital Expenditures	-109.78	-102.94	-55.13	-41.24	-36.57
Cash Acquisitions	-114.07	-114.07	-31.05	-19.91	-232.55
Divestitures	1.81	1.81	3.51	3.37	3.62
Sale (Purchase) of Intangibles	-35.2	-20.25	-30.18	-2.98	-29.15
Investing Cash Flow	-257.5	-235.45	-112.86	-60.75	-294.64
Long-Term Debt Issued	-	3,247	1,480	145	266.75
Long-Term Debt Repaid	-	-4,236	-1,488	-169.31	-24.38
Net Debt Issued (Repaid)	-964.18	-988.51	-8.8	-24.31	242.37
Issuance of Common Stock	1,203	1,203	-	-	-
Other Financing Activities	-9.94	-10.54	-5.89	-1.47	-9.18
Financing Cash Flow	228.69	203.76	-14.69	-25.78	233.19
Foreign Exchange Rate Adjustments	-0.42	-0.04	-2.43	-3.85	-3.41
Net Cash Flow	106.66	44.6	-62.08	-63.12	65.88
Free Cash Flow	26.11	-26.61	12.76	-13.98	94.18
Free Cash Flow Margin	0.48%	-0.51%	0.28%	-0.34%	2.71%
Free Cash Flow Per Share	0.09	-0.09	0.05	-0.05	0.34
Cash Interest Paid	291.15	291.15	297.33	228.26	193.36
Cash Income Tax Paid	101.65	101.65	99.51	40.53	29.82
Levered Free Cash Flow	-	60.3	45.63	-	-
Unlevered Free Cash Flow	-	224.94	223.85	-	-
Change in Net Working Capital	-	109.2	99.75	-	-

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q